Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Affymax Inc (AFFY)  
$0.00 0.00 (200.00%) as of 4:30 Mon 4/22


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 37,490,000
Market Cap: 78.73(K)
Last Volume: 1,574 Avg Vol: 36,164
52 Week Range: $0.0002 - $0.04
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
    NASDAQ COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Affymax is a biopharmaceutical company in the process of restructuring operations. Co.'s U.S. Food and Drug Administration approved product, OMONTYS® (peginesatide) Injection for the treatment of anemia due to chronic kidney disease in adult patients on dialysis, has been recalled. As a result of the voluntary recall of OMONTYS, all marketing activities were suspended and sales were ceased. Co. granted its collaboration partner, Takeda Pharmaceutical Company Limited, a license to OMONTYS.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 0 0 0 0
Total Sell Value $0 $0 $0 $0
Total People Sold 0 0 0 0
Total Sell Transactions 0 0 0 0
End Date 2024-01-21 2023-10-20 2023-04-21 2022-04-21

   
Records found: 225
  Page 1 of 9  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Walker John Peter Director   –       •      –    2013-08-28 4 S $1.92 $31,761 D/D (16,540) 0     -
   Knapp Jeffrey H Chief Commercial Officer   •       –      –    2013-02-15 4 AS $15.76 $36,686 D/D (2,328) 18,125     -
   Knapp Jeffrey H Chief Commercial Officer   •       –      –    2013-02-15 4 OE $6.23 $16,517 D/D 2,328 20,453     -
   Orwin John A CEO   •       •      –    2013-02-01 4 AS $18.81 $119,744 D/D (6,366) 108,000     -
   Orwin John A CEO   •       •      –    2013-02-01 4 OE $5.83 $41,571 D/D 6,366 114,366     -
   Orwin John A CEO   •       •      –    2013-01-30 4 A $0.00 $0 D/D 16,000 108,000     -
   Cross Herb Chief Financial Officer   •       –      –    2013-01-30 4 A $0.00 $0 D/D 5,000 21,370     -
   Duliege Anne-Marie Chief Medical Officer   •       –      –    2013-01-30 4 A $0.00 $0 D/D 5,000 28,125     -
   Knapp Jeffrey H Chief Commercial Officer   •       –      –    2013-01-30 4 A $0.00 $0 D/D 5,000 18,125     -
   Knapp Jeffrey H Chief Commercial Officer   •       –      –    2013-01-15 4 AS $21.25 $141,560 D/D (6,661) 13,125     -
   Knapp Jeffrey H Chief Commercial Officer   •       –      –    2013-01-15 4 OE $6.23 $93,573 D/D 6,661 19,786     -
   Knapp Jeffrey H Chief Commercial Officer   •       –      –    2012-12-17 4 AS $22.31 $149,316 D/D (6,694) 13,125     -
   Knapp Jeffrey H Chief Commercial Officer   •       –      –    2012-12-17 4 OE $6.23 $93,784 D/D 6,694 19,819     -
   Laporte Kathleen Director   –       •      –    2012-12-14 4 S $22.72 $113,600 D/D (5,000) 0     -
   Laporte Kathleen Director   –       •      –    2012-12-14 4 OE $14.24 $77,575 D/D 5,000 5,000     -
   Orwin John A CEO   •       •      –    2012-12-03 4 AS $24.22 $382,628 D/D (15,798) 92,000     -
   Orwin John A CEO   •       •      –    2012-12-03 4 OE $5.83 $105,475 D/D 15,798 107,798     -
   Venteicher Robert SVP, Technical Operations   •       –      –    2012-11-23 4 AS $24.00 $19,992 D/D (833) 24,994     -
   Venteicher Robert SVP, Technical Operations   •       –      –    2012-11-23 4 OE $5.83 $4,856 D/D 833 25,827     -
   Knapp Jeffrey H Chief Commercial Officer   •       –      –    2012-11-19 4 AS $23.00 $23,000 D/D (1,000) 13,125     -
   Knapp Jeffrey H Chief Commercial Officer   •       –      –    2012-11-19 4 OE $21.74 $21,740 D/D 1,000 14,125     -
   Knapp Jeffrey H Chief Commercial Officer   •       –      –    2012-11-15 4 AS $22.62 $131,942 D/D (5,833) 13,125     -
   Knapp Jeffrey H Chief Commercial Officer   •       –      –    2012-11-15 4 OE $6.23 $88,858 D/D 5,833 18,958     -
   Venteicher Robert SVP, Technical Operations   •       –      –    2012-11-02 4 AS $23.63 $28,238 D/D (1,195) 24,994     -
   Venteicher Robert SVP, Technical Operations   •       –      –    2012-11-02 4 OE $7.99 $11,609 D/D 1,195 26,189     -
  225 Records found
  1  2  3  4  5  6  7  8  9   
  Page 1 of 9
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us